Optimised cell culture development for pharma, biotech, CMOs and media providers
Dr. Berthold Bödeker is Chief Scientist and heading pilot plants and cell culture at the CMC unit of Global Drug Discovery-Biological Development of Bayer Schering Pharma AG in Wuppertal, Germany, which is responsible for the technical development and clinical mate…more ›
Starting with an Engineering degree coupled with a doctorate in Physiology, Hervé Broly developed the manufacture of monoclonal antibodies for diagnostic reagent and therapeutical use at the Regional Blood Transfusion Center of Lille (France) from 1982 to 1991 and …more ›
Born in Quebec City (Canada), Dr. Philippe-Alexandre Gilbert is a graduate of the department of biochemistry at the University of Ottawa . He pursued his education at Laval University where he obtained his masters degree in molecular biology and his doctorate in bioche…more ›
Thomas completed his PhD in Biochemistry and Biotechnology in 1992 at the Technical University of Braunschweig, Germany. After a year PostDoc he joined Genentech in 1993. At Genentech he was involved in the development of the first generation of commercial antibody proc…more ›
Dry Powder Mammalian Cell Culture media production: From Easy going to sophistication - a case study DMEM / F12 production • Physico chemical characterisation of DMEM / F12 • Batch to batch consistency: the grail in media production and supply • …more ›
Venue change due to unprecedented demand
The 2nd annual Cell Culture World Congress, Europe’s leading technical congress and exhibition focused on the development and optimisation of cell culture bioproduction is now moving to the Westin Grand Munchen.
Explore the problem-points for each stage in the production cycle; moving from media selection and the challenges of screening, through to an indepth view of the main concerns of USP facing all stakeholders: is small scale multiple product production the answer? Can single use technologies be used safely for vaccine production?
Sponsors
Are you facing any of this issues?
- Can cell culture procedures become more proficient
whilst keeping costs to a minimum? - Which strategies have yielded the best results for
improving expression predictability? - What are the cutting edge strategies for reducing
production times? - Who is exploring the techniques for achieving
efficient scaling procedures to maximize your bioprocessing efficiency?
The Cell Culture World Congress will bring together pioneers in the cell culture and cell line engineering field, offering attendees a unique opportunity to solve these challenges and many more.
Come to Cell Culture World Congress and learn about:
- Cell line development and culture strategies; optimal bioprocessing
- Upstream bioprocessing: cell culture expression system evolution
- Preferences in media types vying for dominance in the market
- Advantages/disadvantages of cell culture systems, cell lines and cell banks
- Cell lines for bioproduction and predominant cell lines
You’ll come away with great new ideas to do better business.
Who Should attend Europe's Cell Culture conference?
- Big Pharma
- Big Biotech
- Small and Medium pharma
- Specialised Biotech
- EQMs
- Platform Technology Providers
- Contract Service providers
- Academia research
- Government and regulatory affairs
- Venture Capitalists
Who should sponsor:
- Pharma/Biotechs
- Contract research organisations
- Contract Manufacturing organisations
- Platform Technology Providers
- Media Suppliers
- OEM/Equipment Providers
- Law Firms
- Consultants
This is the single most important antibody focused business development event you can attend this year.
